Copyright
©The Author(s) 2015.
World J Gastroenterol. Apr 7, 2015; 21(13): 3912-3920
Published online Apr 7, 2015. doi: 10.3748/wjg.v21.i13.3912
Published online Apr 7, 2015. doi: 10.3748/wjg.v21.i13.3912
Figure 2 Kaplan-Meyer survival analysis by groups.
Group A: patients receiving antiviral therapy who achieved a SVR; Group B: patients receiving antiviral therapy who were NR; Group C: patients untreated with mild recurrence; Group D: patients too sick to be treated; Group E: patients with clinically relevant comorbidities that contraindicated antiviral therapy. SVR: Sustained virological response; NR: Non-response.
- Citation: Gitto S, Belli LS, Vukotic R, Lorenzini S, Airoldi A, Cicero AFG, Vangeli M, Brodosi L, Panno AM, Di Donato R, Cescon M, Grazi GL, De Carlis L, Pinna AD, Bernardi M, Andreone P. Hepatitis C virus recurrence after liver transplantation: A 10-year evaluation. World J Gastroenterol 2015; 21(13): 3912-3920
- URL: https://www.wjgnet.com/1007-9327/full/v21/i13/3912.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i13.3912